0 Commentarios
0 Acciones
478 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The large scale Adalimumab Biosimilar Marketing report...0 Commentarios 0 Acciones 601 Views 0 Vista previa
-
Anti-Rheumatics Market Size to Reach USD 84.18 Billion by 2033, Driven by Rising Prevalence of Autoimmune DisordersMarket Overview The global Anti-Rheumatics Market is witnessing steady growth, driven by the increasing prevalence of autoimmune diseases such as rheumatoid arthritis and other inflammatory conditions. According to the latest report by Straits Research, the market was valued at USD 66.24 billion in 2024 and is projected to reach USD 84.18 billion by 2033, growing at a CAGR of 2.7% during...0 Commentarios 0 Acciones 724 Views 0 Vista previa
-
Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory DisordersAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...0 Commentarios 0 Acciones 301 Views 0 Vista previa
-
Janus Kinase (JAK) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. To impart a supreme quality to...0 Commentarios 0 Acciones 487 Views 0 Vista previa
© 2026 Myliveroom — Live Events & Online Communities
Spanish